Cargando...
Rivaroxaban versus warfarin for the management of left ventricle thrombus
BACKGROUND: Rivaroxaban has been recently introduced for the management of non-valvular intra-cardiac thrombosis with variable results. We aimed to compare the results of the off-label use of rivaroxaban versus warfarin in the management of patients with left ventricle (LV) thrombus. This research i...
Guardado en:
| Publicado en: | Egypt Heart J |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8088413/ https://ncbi.nlm.nih.gov/pubmed/33932172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s43044-021-00164-7 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|